Measuring human carboxylesterase 2 activity in pancreatic cancer patient-derived xenografts using a ratiometric fluorescent chemosensor

Irinotecan-based therapy is a common treatment for pancreatic cancer. To elicit its anticancer activity, the drug requires first the hydrolysis action of the enzyme human carboxylesterase 2 (hCES2). It has been established that pancreatic cancer patients have various levels of hCES2, whereby patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Kailass, Karishma, Sadovski, Oleg, Capello, Michela, Kang, Ya'an, Fleming, Jason B., Hanash, Samir M., Beharry, Andrew A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal Society of Chemistry 2019
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844279/
https://www.ncbi.nlm.nih.gov/pubmed/31803422
http://dx.doi.org/10.1039/c9sc00283a

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844279/
https://www.ncbi.nlm.nih.gov/pubmed/31803422
http://dx.doi.org/10.1039/c9sc00283a

Ejemplares similares